The effect of indomethacin on anthralin inflammation.
The effect of prostaglandin inhibition, using topical indomethacin, on anthralin inflammation was studied. Indomethacin gel and gel base were applied to opposite flexor forearm skin sites of 11 volunteers for 2 h and then washed off. Anthralin and UVB were then applied to the gel-treated skin and the anthralin- and UVB-induced erythema and oedema were measured at 2, 6, 24 and 48 h using Harpenden callipers and a reflectance erythrometer. Prostaglandin inhibition was demonstrated by a significant reduction of UVB erythema at the indomethacin-treated sites compared to the gel-base-treated sites. There was a small but significant reduction in anthralin erythema, but not oedema, at the indomethacin-treated sites compared to the gel-base sites. This study demonstrates that prostaglandins, and other inflammatory mediators because the inhibitory effect was small, are involved in anthralin inflammation.
Ramsay
B
B
Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, U.K.
Rice
N
N
Lawrence
C
C
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000875:Anthralin / Q000009:adverse effects*; D003877:Dermatitis, Contact / Q000517:prevention & control*; D004487:Edema / Q000139:chemically induced / Q000517:prevention & control; D004890:Erythema / Q000139:chemically induced / Q000517:prevention & control; D005260:Female; D005782:Gels; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012867:Skin / Q000528:radiation effects; D014466:Ultraviolet Rays
D005782:Gels; D000875:Anthralin; D007213:Indomethacin